Stockreport

Vir Biotechnology, Inc. (NASDAQ:VIR) is largely controlled by institutional shareholders who own 53% of the company [Yahoo! Finance]

Vir Biotechnology, Inc.  (VIR) 
PDF A total of 6 investors have a majority stake in the company with 53% ownership Ownership research along with analyst forecasts data help provide a good understanding [Read more]